Several inflammation-associated receptors are known to exert relevant effects on ovarian cancer cells: bradykinin and several chemokines can trigger intracellular Ca2+ signals in ovarian cancer cells [214], and relaxin production is induced by inflammation, activating prooncogenic pathways via the LGR7 (RXFP1) receptor. Here, RXFP1 is linked to ovarian carcinoma.